1. Home
  2. YAAS vs VYNE Comparison

YAAS vs VYNE Comparison

Compare YAAS & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YAAS
  • VYNE
  • Stock Information
  • Founded
  • YAAS 2018
  • VYNE 2003
  • Country
  • YAAS China
  • VYNE United States
  • Employees
  • YAAS N/A
  • VYNE N/A
  • Industry
  • YAAS Computer Software: Prepackaged Software
  • VYNE Biotechnology: Pharmaceutical Preparations
  • Sector
  • YAAS Technology
  • VYNE Health Care
  • Exchange
  • YAAS Nasdaq
  • VYNE Nasdaq
  • Market Cap
  • YAAS 9.5M
  • VYNE 9.6M
  • IPO Year
  • YAAS 2024
  • VYNE 2018
  • Fundamental
  • Price
  • YAAS $2.46
  • VYNE $0.35
  • Analyst Decision
  • YAAS
  • VYNE Buy
  • Analyst Count
  • YAAS 0
  • VYNE 2
  • Target Price
  • YAAS N/A
  • VYNE $8.00
  • AVG Volume (30 Days)
  • YAAS 489.8K
  • VYNE 3.1M
  • Earning Date
  • YAAS 07-14-2025
  • VYNE 11-10-2025
  • Dividend Yield
  • YAAS N/A
  • VYNE N/A
  • EPS Growth
  • YAAS N/A
  • VYNE N/A
  • EPS
  • YAAS N/A
  • VYNE N/A
  • Revenue
  • YAAS $581,862.00
  • VYNE $476,000.00
  • Revenue This Year
  • YAAS N/A
  • VYNE N/A
  • Revenue Next Year
  • YAAS N/A
  • VYNE N/A
  • P/E Ratio
  • YAAS N/A
  • VYNE N/A
  • Revenue Growth
  • YAAS N/A
  • VYNE N/A
  • 52 Week Low
  • YAAS $2.26
  • VYNE $0.28
  • 52 Week High
  • YAAS $560.00
  • VYNE $4.30
  • Technical
  • Relative Strength Index (RSI)
  • YAAS 56.66
  • VYNE 45.19
  • Support Level
  • YAAS $2.26
  • VYNE $0.34
  • Resistance Level
  • YAAS $2.59
  • VYNE $0.38
  • Average True Range (ATR)
  • YAAS 0.19
  • VYNE 0.03
  • MACD
  • YAAS -0.12
  • VYNE 0.00
  • Stochastic Oscillator
  • YAAS 20.00
  • VYNE 16.76

About YAAS Youxin Technology Ltd

Youxin Technology Ltd is a SaaS and PaaS provider committed to helping retail enterprises digitally transform their businesses to develop, use and control business applications without the need to purchase complex IT infrastructure. The company leverages the technologies used to develop its PaaS platform to standardize customized customer relationship management, or CRM, services to its clients that seamlessly connect all levels of the retail chain from management teams to customers. Its products give its retail clients a comprehensive view of their business operations in real-time on multiple interfaces, allowing them to make critical business decisions anytime and anywhere. Geographically operates in PRC, Hong Kong, and Cayman Island.

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

Share on Social Networks: